rs648705
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_001845.6(COL4A1):c.958-199T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.573 in 152,030 control chromosomes in the GnomAD database, including 25,982 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.57 ( 25982 hom., cov: 33)
Consequence
COL4A1
NM_001845.6 intron
NM_001845.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.597
Publications
5 publications found
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
- brain small vessel disease 1 with or without ocular anomaliesInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
- autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndromeInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
- microangiopathy and leukoencephalopathy, pontine, autosomal dominantInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- familial porencephalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- pontine autosomal dominant microangiopathy with leukoencephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- retinal arterial tortuosityInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- muscular dystrophy-dystroglycanopathy, type AInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 13-110203806-A-C is Benign according to our data. Variant chr13-110203806-A-C is described in ClinVar as Benign. ClinVar VariationId is 1293046.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.742 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.574 AC: 87164AN: 151912Hom.: 25986 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
87164
AN:
151912
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.573 AC: 87174AN: 152030Hom.: 25982 Cov.: 33 AF XY: 0.575 AC XY: 42749AN XY: 74314 show subpopulations
GnomAD4 genome
AF:
AC:
87174
AN:
152030
Hom.:
Cov.:
33
AF XY:
AC XY:
42749
AN XY:
74314
show subpopulations
African (AFR)
AF:
AC:
17094
AN:
41460
American (AMR)
AF:
AC:
8296
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
2422
AN:
3470
East Asian (EAS)
AF:
AC:
3933
AN:
5160
South Asian (SAS)
AF:
AC:
3374
AN:
4820
European-Finnish (FIN)
AF:
AC:
6425
AN:
10550
Middle Eastern (MID)
AF:
AC:
185
AN:
294
European-Non Finnish (NFE)
AF:
AC:
43345
AN:
67974
Other (OTH)
AF:
AC:
1300
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1812
3624
5437
7249
9061
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
742
1484
2226
2968
3710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2379
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.